// App-Quantinova.ai

1356 : Establishment of Novel Leukemic Cell Lines Resistant to Clofarabine by Dual Mechanisms of Decreased Active Metabolite and Increased Antiapoptotic Factor

Researchers

Presenter

  • Takahiro Yamauchi

Principal Investigators

  • Takanori Ueda

Medical Centers

  • Department of Hematology and Oncology, University of Fukui, Fukui, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Human equilibrative nucleoside transporter 1

Drug/Treatment

  • Decitabine

  • Clofarabine

  • Gemcitabine

  • Cladribine

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved